drugset / Trial / NCT00865007

Lopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat Recovery in Persons With Lipoatrophy

NCT00865007

Phase 4 Completed 88 enrolled Fundacion SEIMC-GESIDA Abbott · collab
RandomizedParallel-groupOpen-labelPrevention

Summary

The aim of this study is to evaluate the efficacy for the recovery of peripheral fat of lopinavir/ritonavir in monotherapy versus abacavir/lamivudine and lopinavir/ritonavir in subjects who developed lipoatrophy while receiving zidovudine plus lamivudine plus abacavir.

Timeline

Start
2008-12
Primary completion
2012-06
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Abacavir Other / unclassified
Comparator Lamivudine Other / unclassified
Subject Lopinavir Other / unclassified
Subject Ritonavir Other / unclassified